Cargando…
Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
Cancer specific inhibitors reflective of unique metabolic needs, are rare. We describe a novel small molecule, Gboxin, that specifically inhibits primary mouse and human glioblastoma (GBM) cell growth but not mouse embryo fibroblasts or neonatal astrocytes. Gboxin rapidly and irreversibly compromise...
Autores principales: | Shi, Yufeng, Lim, S. Kyun, Liang, Qiren, Iyer, Swathi V., Wang, Hua-Yu, Wang, Zilai, Xie, Xuanhua, Sun, Daochun, Chen, Yu-Jung, Tabar, Viviane, Gutin, Philip, Williams, Noelle, De Brabander, Jef K., Parada, Luis F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655586/ https://www.ncbi.nlm.nih.gov/pubmed/30842654 http://dx.doi.org/10.1038/s41586-019-0993-x |
Ejemplares similares
-
Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment
por: Zou, Yan, et al.
Publicado: (2023) -
Tumor progression is independent of tumor-associated macrophages in cell lineage–based mouse models of glioblastoma
por: Chipman, Mollie E., et al.
Publicado: (2023) -
Structural basis for itraconazole-mediated NPC1 inhibition
por: Long, Tao, et al.
Publicado: (2020) -
Structural insights for selective disruption of Beclin 1 binding to Bcl-2
por: Pan, Yun-Zu, et al.
Publicado: (2023) -
Cell of Origin and Cancer Stem Cells in Tumor Suppressor Mouse Models of Glioblastoma
por: Alcantara Llaguno, Sheila R., et al.
Publicado: (2016)